A clinical study for puncturing the Bi-Qiu acupoint under the guidance of nasal endoscope in the treatment of perennial allergic rhinitis

Not Applicable

• Conditions: Allergic rhinitis

• Registration Number: ITMCTR1900002831
• Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. those who meet the diagnostic criteria of perennial allergic rhinitis;
2. Aged between 18-60 years old, male and female;
3. the course of disease more than one year;
4. Signed informed consent.

Exclusion Criteria

1. With upper respiratory tract infection, eosinophilia, vasomotor rhinitis, nasal polyp, bronchitis, pneumonia and asthma;
2. pregnant and lactating women;
3. With serious primary heart, liver, lung, kidney, blood diseases and diabetes or serious diseases affecting its survival;
4. those who are unable to give full informed consent due to mental or behavioral disorders;
5. suspected or had a history of alcohol and drug abuse;
6. moderate to severe deviation of nasal septum;
7. H1 antihistamines, steroids and antihistamines, decongestants (acting on nose, mouth, eye position), corticosteroids, antibiotics, etc. were used within last one week;
8. have received specific immunotherapy or systemic hormone therapy in the last year;
9. received acupuncture treatment for the disease within last two weeks.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Questionnaire score of quality of life related to rhinoconjunctivitis;Visual analogue scale score;Score of main symptoms of rhinitis;